Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation

NCT01125020 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation
Hepatocellular Carcinoma
Tumor Recurrence and Metastasis
Survival
Adjuvant Chemotherapy

Interventions

DRUG: gemcitabine and oxaliplatin
DRUG: doxorubicin, 5-Fu and cisplatin

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]